Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Strain

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol DependenceMegan L Ryan, Daniel E Falk, Joanne B Fertig, et al.
Drug and Alcohol Dependence|December 15, 2015
Measures of outcome for stimulant trials: ACTTION recommendations and research agendaBrian D Kiluk, Kathleen M Carroll, Amy Duhig, et al.
Pain|June 24, 2025
Over 50 years of research on social disparities in pain and pain treatment: a scoping review of reviewsHanna Grol-Prokopczyk, Rui Huang, Chang Yu, et al.
Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
Alcoholism, Clinical and Experimental Research|November 8, 2018
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and SafetyDaniel E Falk, Megan L Ryan, Joanne B Fertig, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
The American Journal of Psychiatry|June 16, 2007
Treatment of patients with substance use disorders, second edition. American Psychiatric AssociationHerbert D Kleber, Roger D Weiss, Raymond F Anton, et al.
The American Journal of Psychiatry|September 20, 2006
Treatment of patients with substance use disorders, second edition. American Psychiatic Association, Herbert D Kleber, Roger D Weiss, et al.
Pain|April 17, 2021
Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendationsJennifer S Gewandter, Shannon M Smith, Robert H Dworkin, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol DependenceMegan L Ryan, Daniel E Falk, Joanne B Fertig, et al.
Drug and Alcohol Dependence|December 15, 2015
Measures of outcome for stimulant trials: ACTTION recommendations and research agendaBrian D Kiluk, Kathleen M Carroll, Amy Duhig, et al.
Pain|June 24, 2025
Over 50 years of research on social disparities in pain and pain treatment: a scoping review of reviewsHanna Grol-Prokopczyk, Rui Huang, Chang Yu, et al.
Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
Alcoholism, Clinical and Experimental Research|November 8, 2018
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and SafetyDaniel E Falk, Megan L Ryan, Joanne B Fertig, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
The American Journal of Psychiatry|June 16, 2007
Treatment of patients with substance use disorders, second edition. American Psychiatric AssociationHerbert D Kleber, Roger D Weiss, Raymond F Anton, et al.
The American Journal of Psychiatry|September 20, 2006
Treatment of patients with substance use disorders, second edition. American Psychiatic Association, Herbert D Kleber, Roger D Weiss, et al.
Pain|April 17, 2021
Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendationsJennifer S Gewandter, Shannon M Smith, Robert H Dworkin, et al.
Pageof 16